142 related articles for article (PubMed ID: 38532685)
21. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
Zhang X; Yang H
Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.
Sanchez Calle A; Yamamoto T; Kawamura Y; Hironaka-Mitsuhashi A; Ono M; Tsuda H; Shimomura A; Tamura K; Takeshita F; Ochiya T; Yamamoto Y
Mol Oncol; 2020 Sep; 14(9):2271-2287. PubMed ID: 32392629
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic long noncoding RNA landscape in breast cancer.
Xu S; Kong D; Chen Q; Ping Y; Pang D
Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
[TBL] [Abstract][Full Text] [Related]
24. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
26. Critical roles of long noncoding RNAs in breast cancer.
Abolghasemi M; Tehrani SS; Yousefi T; Karimian A; Mahmoodpoor A; Ghamari A; Jadidi-Niaragh F; Yousefi M; Kafil HS; Bastami M; Edalati M; Eyvazi S; Naghizadeh M; Targhazeh N; Mihanfar A; Yousefi B; Safa A; Majidinia M; Rameshknia V
J Cell Physiol; 2020 Jun; 235(6):5059-5071. PubMed ID: 31951025
[TBL] [Abstract][Full Text] [Related]
27. Primate-specific oestrogen-responsive long non-coding RNAs regulate proliferation and viability of human breast cancer cells.
Lin CY; Kleinbrink EL; Dachet F; Cai J; Ju D; Goldstone A; Wood EJ; Liu K; Jia H; Goustin AS; Kosir MA; Thepsuwan P; Lipovich L
Open Biol; 2016 Dec; 6(12):. PubMed ID: 28003470
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance.
Yousefi H; Maheronnaghsh M; Molaei F; Mashouri L; Reza Aref A; Momeny M; Alahari SK
Oncogene; 2020 Jan; 39(5):953-974. PubMed ID: 31601996
[TBL] [Abstract][Full Text] [Related]
30. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
31. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
[TBL] [Abstract][Full Text] [Related]
32. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
34. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
Eroğlu Güneş C; Güçlü E; Vural H; Kurar E
Gene; 2021 Dec; 805():145904. PubMed ID: 34418470
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
[TBL] [Abstract][Full Text] [Related]
38. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer.
Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y
J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNAs as regulators of epithelial mesenchymal transition in breast cancer: A recent review.
El-Ashmawy NE; Khedr EG; Abo-Saif MA; Hamouda SM
Life Sci; 2024 Jan; 336():122339. PubMed ID: 38097110
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional Microenvironment.
Nuñez-Olvera SI; Aguilar-Arnal L; Cisneros-Villanueva M; Hidalgo-Miranda A; Marchat LA; Salinas-Vera YM; Ramos-Payán R; Pérez-Plasencia C; Carlos-Reyes Á; Puente-Rivera J; López-Camarillo C
Cells; 2022 Nov; 11(21):. PubMed ID: 36359853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
